The SRT-100 Vision™ has many unique features that make treatment safe, comfortable and effective.
For patients and physicians who want the ultimate in advanced Superficial Radiation Therapy technology, Sensus Healthcare offers the SRT-100 Vision™—the next generation of innovation in our powerful arsenal against non-melanoma skin cancer and unsightly keloid scarring.
Built with all the same great features and remarkable efficacy that distinguish the original SRT-100™, the SRT-100 Vision™ delivers the precise, painless calibrated dose of Superficial Radiation Therapy patients and physicians expect, but offers additional features—most notably high-frequency ultrasound for imaging.
With a high-frequency ultra-sound guidance system, the SRT-100 Vision™ allows physicians to view treatment areas while they are being treated. This “see and treat” capability allows basal and squamous cell carcinomas, as well as keloid tissue, to be assessed more thoroughly so treatment can be targeted more precisely. When the ultrasound technology is placed over the treatment area using the laser positioning system, physicians can assess the lesion to see how deep it is and fine tune the exact amount of radiation needed. This will ultimately help tailor each patient’s treatment protocol when physicians are able to see how the lesion is progressing with each treatment session. Not only this, but each treatment session is recorded for patient records with the LesionCam™.
SRT-100™ has many unique features that make treatment safe, comfortable and effective.
For precise beam port positioning and re-positioning on the treatment area.
Provides lesion photo-registration and a video of treatment for patient records.
Facilitate the set up, initiation, monitoring and termination of exposures. The module can be located remotely.
Provides constant bi-directional patient communication.
Applies the correct filter to match the selected energy and beam depth.
Organizes patient scheduling and record management to optimize workflow.
Calculates proper dosing and measures each dose administered during treatment to ensure patient safety and optimal outcomes.
Automatically confirms system calibration each time the system is initiated to ensure the patient is receiving the correct dose and eliminates the need for un-scheduled calibrations.
Finally, dermatologists, radiation oncologists, hospitals, and other care facilities can provide their patients with a non-surgical treatment option that delivers remarkable cure rates while preserving healthy tissue. The innovative SRT-100 Vision™ delivers 98% cure rates for NMSC and 94% plus cure rates for keloids all while eliminating aspects of treatment that often cause anxiety, slow healing and recovery. Like the SRT-100™, the SRT-100 Vision™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and healthcare providers with one or more locations.
